Borealis-2: A randomized phase II study of OGX-427 (apatorsen) plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial cancer (mUC) (Hoosier Cancer Research Network GU12-160) Meeting Abstract
| Authors: | Choueiri, T. K.; Hahn, N. M.; Werner, L.; Regan, M. M.; Rosenberg, J. E. |
| Abstract Title: | Borealis-2: A randomized phase II study of OGX-427 (apatorsen) plus docetaxel versus docetaxel alone in platinum-resistant metastatic urothelial cancer (mUC) (Hoosier Cancer Research Network GU12-160) |
| Meeting Title: | 2017 Gastrointestinal Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 35 |
| Issue: | 6 Suppl. |
| Meeting Dates: | 2017 Jan 19-21 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2017-02-20 |
| Language: | English |
| ACCESSION: | WOS:000443269500351 |
| DOI: | 10.1200/JCO.2017.35.6_suppl.289 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 289 -- Source: Wos |
